Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic hypersensitivity vasculitis associated with bronchiectasis.

E Tanaka1, K Tada, R Amitani

  • 1Department of Infection and Inflammation, First Clinic of Medicine, Kyoto University, Japan.

Chest
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative fractionated high-dose rate brachytherapy for malignant bone and soft tissue tumors.

International journal of radiation oncology, biology, physics·1999
Same author

[Endothelium-dependent relaxation of collateral microvessels following intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia].

Journal of cardiology·1999
Same author

[Hepatitis E].

Ryoikibetsu shokogun shirizu·1999
Same author

[The need for new antituberculosis agents in Japan].

Kekkaku : [Tuberculosis]·1999
Same author

A pilot study of low-dose erythromycin in bronchiectasis.

The European respiratory journal·1999
Same author

Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes.

Journal of clinical pharmacy and therapeutics·1999
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

A man developed systemic vasculitis during a Pseudomonas aeruginosa-infected bronchiectasis flare. Treatment with corticosteroids and cyclophosphamide effectively managed both the vasculitis and bronchiectasis.

Area of Science:

  • Nephrology
  • Rheumatology
  • Pulmonology

Background:

  • Bronchiectasis is a chronic lung condition characterized by permanent enlargement of the airways.
  • Pseudomonas aeruginosa is a common opportunistic pathogen that can cause severe infections in patients with bronchiectasis.
  • Systemic hypersensitivity vasculitis is a group of disorders characterized by inflammation of blood vessels.

Observation:

  • A 53-year-old male patient experienced an acute exacerbation of bronchiectasis due to Pseudomonas aeruginosa infection.
  • The patient presented with high-grade fever, mononeuropathy multiplex, and cutaneous vasculitis.
  • Kidney biopsy confirmed mesangioproliferative glomerulonephritis with crescent formation and leukocytoclastic vasculitis, indicative of a systemic immune complex-mediated process.

Findings:

Related Experiment Videos

  • The patient's presentation was consistent with systemic hypersensitivity vasculitis triggered by a Pseudomonas aeruginosa infection in the context of bronchiectasis.
  • Biopsy findings confirmed leukocytoclastic vasculitis and glomerulonephritis, associated with circulating immune complexes.
  • The therapeutic regimen combining corticosteroids and cyclophosphamide demonstrated efficacy in treating both the vasculitis and the underlying bronchiectasis exacerbation.

Implications:

  • This case highlights a rare but serious complication of Pseudomonas aeruginosa-infected bronchiectasis, emphasizing the need for vigilant monitoring for systemic vasculitis.
  • The successful treatment outcome suggests that immunosuppressive therapy, in conjunction with appropriate antimicrobial treatment, can be effective in managing such complex cases.
  • Further research may elucidate the specific mechanisms linking Pseudomonas aeruginosa infection in bronchiectasis to the development of systemic vasculitis and immune complex glomerulonephritis.